Sage Therapeutics Balance Sheet - Annual (NASDAQ:SAGE)

Add to My Stocks
$146.96 $1.83 (1.26%) SAGE stock closing price Sep 18, 2018 (Closing)

The Sage Therapeutics balance sheet is a snapshot of the company's financial health at a given point of time, whereas the other two financial statements are for a particular accounting period. Financial strength can be guaged by performing Sage Therapeutics stock analysis and by analyzing the balance sheet. A company releases its balance sheet every year along with its annual results. The balance sheet shows total liabilities of $54.46M and shareholders equity of $475.47M. Sage Therapeutics revenue and Sage Therapeutics operating cash flow are important in understanding the financial capacity of the company.

View latest 10 year balance sheet data to check Sage Therapeutics financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012
Cash306.23M168.51M186.75M127.76M8.06M-
Marketable Securities212.61M228.96M----
Receivables------
Inventory------
Raw Materials------
Work In Progress------
Finished Goods------
Notes Receivable------
Other Current Assets6.22M5.1M1.73M1.05M--
Total Current Assets
525.07M402.57M188.49M128.82M8.4M-
Property Plant & Equipment5.08M1.93M----
Accumulated Depreciation1.07M-----
Net Property Plant & Equipment
4.01M1.38M----
Investment & Advances------
Other Non-Current Assets------
Deferred Charges------
Intangibles------
Deposits & Other Assets------
Total Assets
529.93M404.53M189.01M129.66M8.53M-
Notes Payable------
Accounts Payable9.35M12.81M5.15M2.42M1.98M-
Current Portion Long-Term Debt------
Current Portion Capital Leases------
Accrued Expenses42.6M22.35M10.14M4.68M--
Income Taxes Payable------
Other Current Liabilities------
Total Current Liabilities
51.95M35.16M15.3M7.75M2.31M-
Mortgages------
Deferred Taxes/Income------
Convertible Debt------
Long-Term Debt------
Non-Current Capital Leases------
Other Long-Term Liabilities2.51M-----
Total Liabilities
54.46M36.01M15.32M7.78M40.06M-
Minority Interest----37.7M-
Preferred Stock------
Common Stock Net------
Capital Surplus1.07B688.95M335.03M188.72M--
Retained Earnings-590.44M-320.32M-161.34M-66.84M-31.67M-
Treasury Stock------
Other Liabilities-0.02M-0.1M----
Shareholders Equity475.47M368.51M173.69M121.88M-31.53M-
Total Liabilities & Shareholders Equity529.93M404.53M189.01M129.66M8.53M-
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Looking at Sage Therapeutics historical stock prices and the current Sage Therapeutics stock price can tell you how the stock price has moved, whereas the Sage Therapeutics PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: An asset is a resource that a corporation like Sage Therapeutics owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for SAGE stock as of 2017 is $529.93M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Sage Therapeutics's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for SAGE stock stand at $54.46M.

Sage Therapeutics Balance Sheet - Key Ratios